Literature DB >> 18449201

High plasma aldosterone and low renin predict blood pressure increase and hypertension in middle-aged Caucasian populations.

P Meneton1, P Galan, S Bertrais, D Heudes, S Hercberg, J Ménard.   

Abstract

Plasma aldosterone and renin levels have been associated with blood pressure increase and 3-4 year incidence of hypertension in a middle-aged North American community in Framingham. To confirm these findings in a different population, a nested case-control study was performed in a national sample of 1984 French non-hypertensive volunteers aged 45-64 year and followed for 5 years. Cases and controls (individuals becoming hypertensive or remaining non-hypertensive on follow-up) were individually matched on sex, diastolic and systolic pressures at baseline. Multivariable regression models show that plasma aldosterone and renin are respectively positively and negatively associated with the increase in systolic pressure (P=0.01 and 0.001) and the risk of hypertension (22% increase and 16% decrease per s.d. increment in the log, P=0.04 and 0.07). These associations are mostly observed in the lowest tertiles of dietary sodium and potassium intakes where plasma aldosterone is positively associated with the increase in systolic pressure (P=0.01 and 0.08) and the risk of hypertension (59 and 69% increase per s.d. increment in the log, P=0.02 and 0.01), whereas plasma renin is negatively associated with the increase in systolic pressure (P=0.0004 and 0.004) and the risk of hypertension (31 and 28% decrease per s.d. increment in the log, P=0.03 and 0.05). These results reinforce the hypothesis that high plasma aldosterone and low plasma renin levels precede blood pressure increase and the occurrence of hypertension in middle-aged Caucasian populations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18449201     DOI: 10.1038/jhh.2008.27

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  13 in total

1.  Adrenal Tissue-Specific Deletion of TASK Channels Causes Aldosterone-Driven Angiotensin II-Independent Hypertension.

Authors:  Nick A Guagliardo; Junlan Yao; Eric J Stipes; Sylvia Cechova; Thu H Le; Douglas A Bayliss; David T Breault; Paula Q Barrett
Journal:  Hypertension       Date:  2019-02       Impact factor: 10.190

2.  Renal Na-handling defect associated with PER1-dependent nondipping hypertension in male mice.

Authors:  Lauren G Douma; Meaghan R Holzworth; Kristen Solocinski; Sarah H Masten; Amber H Miller; Kit-Yan Cheng; I Jeanette Lynch; Brian D Cain; Charles S Wingo; Michelle L Gumz
Journal:  Am J Physiol Renal Physiol       Date:  2018-01-10

3.  Female C57BL/6J mice lacking the circadian clock protein PER1 are protected from nondipping hypertension.

Authors:  Lauren G Douma; Kristen Solocinski; Meaghan R Holzworth; G Ryan Crislip; Sarah H Masten; Amber H Miller; Kit-Yan Cheng; I Jeanette Lynch; Brian D Cain; Charles S Wingo; Michelle L Gumz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-11-14       Impact factor: 3.619

Review 4.  Aldosterone and arterial hypertension.

Authors:  Andreas Tomaschitz; Stefan Pilz; Eberhard Ritz; Barbara Obermayer-Pietsch; Thomas R Pieber
Journal:  Nat Rev Endocrinol       Date:  2009-12-22       Impact factor: 43.330

5.  Direct and indirect inhibition of the circadian clock protein Per1: effects on ENaC and blood pressure.

Authors:  Abdel Alli; Ling Yu; Meaghan Holzworth; Jacob Richards; Kit-Yan Cheng; I Jeanette Lynch; Charles S Wingo; Michelle L Gumz
Journal:  Am J Physiol Renal Physiol       Date:  2019-02-13

6.  TASK-3 channel deletion in mice recapitulates low-renin essential hypertension.

Authors:  Nick A Guagliardo; Junlan Yao; Changlong Hu; Elaine M Schertz; David A Tyson; Robert M Carey; Douglas A Bayliss; Paula Q Barrett
Journal:  Hypertension       Date:  2012-04-09       Impact factor: 10.190

7.  Kidney-specific KO of the circadian clock protein PER1 alters renal Na+ handling, aldosterone levels, and kidney/adrenal gene expression.

Authors:  Lauren G Douma; Hannah M Costello; G Ryan Crislip; Kit-Yan Cheng; I Jeanette Lynch; Alexandria Juffre; Dominique Barral; Sarah Masten; Emilio Roig; Kevin Beguiristain; Wendy Li; Phillip Bratanatawira; Charles S Wingo; Michelle L Gumz
Journal:  Am J Physiol Renal Physiol       Date:  2022-02-07

Review 8.  Whole grains, type 2 diabetes, coronary heart disease, and hypertension: links to the aleurone preferred over indigestible fiber.

Authors:  Stephen Lillioja; Andrew L Neal; Linda Tapsell; David R Jacobs
Journal:  Biofactors       Date:  2013-01-28       Impact factor: 6.113

Review 9.  Pharmacology of Aldosterone and the Effects of Mineralocorticoid Receptor Blockade on Cardiovascular Systems.

Authors:  Shusuke Yagi; Masashi Akaike; Ken-Ichi Aihara; Daiju Fukuda; Masayoshi Ishida; Takayuki Ise; Toshiyuki Niki; Yuka Sumitomo-Ueda; Koji Yamaguchi; Takashi Iwase; Yoshio Taketani; Hirotsugu Yamada; Takeshi Soeki; Tetsuzo Wakatsuki; Michio Shimabukuro; Masataka Sata
Journal:  Acta Cardiol Sin       Date:  2013-05       Impact factor: 2.672

Review 10.  Aldosterone synthase inhibition in hypertension.

Authors:  Karl Andersen
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.